These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men. Akduman B, Alkibay T, Tuncel A, Bozkirli I. Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873 [Abstract] [Full Text] [Related]
6. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830 [Abstract] [Full Text] [Related]
11. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together. Serdar MA, Oguz O, Olgun A, Seçkin B, Ilgan S, Hasimi A, Salih M, Peker F, Kutluay T. Ann Clin Lab Sci; 2002 Jul; 32(1):22-30. PubMed ID: 11848613 [Abstract] [Full Text] [Related]
12. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM. J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995 [Abstract] [Full Text] [Related]
13. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores. Bulbul MA, Khauli RB, Nasr R, Hemady K, Wazzan W. J Med Liban; 2000 Sep; 48(2):59-62. PubMed ID: 11028151 [Abstract] [Full Text] [Related]
15. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases. Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F. Ann Clin Lab Sci; 2003 Sep; 33(3):320-3. PubMed ID: 12956448 [Abstract] [Full Text] [Related]